Annual Non Current Assets
$472.50 M
+$287.64 M+155.59%
December 31, 2023
Summary
- As of February 22, 2025, IOVA annual long term assets is $472.50 million, with the most recent change of +$287.64 million (+155.59%) on December 31, 2023.
- During the last 3 years, IOVA annual non current assets has risen by +$340.14 million (+256.99%).
- IOVA annual non current assets is now at all-time high.
Performance
IOVA Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$492.54 M
+$10.47 M+2.17%
September 30, 2024
Summary
- As of February 22, 2025, IOVA quarterly long term assets is $492.54 million, with the most recent change of +$10.47 million (+2.17%) on September 30, 2024.
- Over the past year, IOVA quarterly non current assets has increased by +$8.24 million (+1.70%).
- IOVA quarterly non current assets is now at all-time high.
Performance
IOVA Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
IOVA Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +155.6% | +1.7% |
| 3 y3 years | +257.0% | +174.7% |
| 5 y5 years | +8574.5% | +174.7% |
IOVA Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +155.6% | at high | +179.8% |
| 5 y | 5-year | at high | +1577.8% | at high | +1648.9% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Iovance Biotherapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $492.54 M(+2.2%) |
| Jun 2024 | - | $482.06 M(-0.5%) |
| Mar 2024 | - | $484.30 M(+2.5%) |
| Dec 2023 | $307.85 M(-35.7%) | $472.50 M(+0.6%) |
| Sep 2023 | - | $469.73 M(-2.6%) |
| Jun 2023 | - | $482.42 M(+158.0%) |
| Mar 2023 | - | $186.99 M(+1.1%) |
| Dec 2022 | $479.12 M(-5.7%) | $184.87 M(+5.0%) |
| Sep 2022 | - | $176.04 M(-1.8%) |
| Jun 2022 | - | $179.28 M(-15.1%) |
| Mar 2022 | - | $211.28 M(-21.6%) |
| Dec 2021 | $507.96 M(-20.1%) | $269.38 M(+9.6%) |
| Sep 2021 | - | $245.80 M(+32.0%) |
| Jun 2021 | - | $186.15 M(+28.1%) |
| Mar 2021 | - | $145.35 M(+9.8%) |
| Dec 2020 | $636.10 M(+101.0%) | $132.36 M(+125.5%) |
| Sep 2020 | - | $58.70 M(+68.1%) |
| Jun 2020 | - | $34.91 M(+9.4%) |
| Mar 2020 | - | $31.92 M(+13.3%) |
| Dec 2019 | $316.49 M(-33.4%) | $28.16 M(-1.0%) |
| Sep 2019 | - | $28.44 M(+13.8%) |
| Jun 2019 | - | $24.99 M(+49.2%) |
| Mar 2019 | - | $16.75 M(+207.5%) |
| Dec 2018 | $475.37 M(+218.4%) | $5.45 M(+9.6%) |
| Sep 2018 | - | $4.97 M(+0.0%) |
| Jun 2018 | - | $4.97 M(+9.9%) |
| Mar 2018 | - | $4.52 M(-25.7%) |
| Dec 2017 | $149.29 M(-11.9%) | $6.08 M(+134.4%) |
| Sep 2017 | - | $2.60 M(+0.7%) |
| Jun 2017 | - | $2.58 M(-7.8%) |
| Mar 2017 | - | $2.80 M(+17.8%) |
| Dec 2016 | $169.51 M | $2.37 M(+34.2%) |
| Sep 2016 | - | $1.77 M(+48.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2016 | - | $1.19 M(-15.4%) |
| Mar 2016 | - | $1.41 M(-15.9%) |
| Dec 2015 | $103.98 M(+131.2%) | $1.68 M(-8.6%) |
| Sep 2015 | - | $1.83 M(-9.5%) |
| Jun 2015 | - | $2.03 M(-4.8%) |
| Mar 2015 | - | $2.13 M(+38.9%) |
| Dec 2014 | $44.98 M(+126.6%) | $1.53 M(+723.2%) |
| Sep 2014 | - | $186.10 K(+1077.8%) |
| Jun 2014 | - | $15.80 K(+8.2%) |
| Mar 2014 | - | $14.60 K(-47.5%) |
| Dec 2013 | $19.85 M(>+9900.0%) | $27.80 K(-7.0%) |
| Sep 2013 | - | $29.90 K(+57.4%) |
| Jun 2013 | - | $19.00 K(-5.9%) |
| Mar 2013 | - | $20.20 K(-8.6%) |
| Dec 2012 | $7300.00(-98.6%) | $22.10 K(-6.8%) |
| Sep 2012 | - | $23.70 K(-42.5%) |
| Jun 2012 | - | $41.20 K(-3.7%) |
| Mar 2012 | - | $42.80 K(-3.4%) |
| Dec 2011 | $524.10 K(-59.7%) | $44.30 K(-68.5%) |
| Sep 2011 | - | $140.50 K(+0.3%) |
| Jun 2011 | - | $140.10 K(-1.3%) |
| Mar 2011 | - | $141.90 K(-11.3%) |
| Dec 2010 | $1.30 M(>+9900.0%) | $160.00 K(-27.0%) |
| Sep 2010 | - | $219.10 K(-0.1%) |
| Jun 2010 | - | $219.30 K(-0.1%) |
| Mar 2010 | - | $219.50 K(>+9900.0%) |
| Dec 2009 | $8400.00(+171.0%) | $1200.00(-25.0%) |
| Sep 2009 | - | $1600.00(-15.8%) |
| Jun 2009 | - | $1900.00(-13.6%) |
| Mar 2009 | - | $2200.00(-15.4%) |
| Dec 2008 | $3100.00 | $2600.00(-10.3%) |
| Sep 2008 | - | $2900.00(-9.4%) |
| Jun 2008 | - | $3200.00(-11.1%) |
| Mar 2008 | - | $3600.00 |
FAQ
- What is Iovance Biotherapeutics annual long term assets?
- What is the all time high annual non current assets for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics annual non current assets year-on-year change?
- What is Iovance Biotherapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics quarterly non current assets year-on-year change?
What is Iovance Biotherapeutics annual long term assets?
The current annual non current assets of IOVA is $472.50 M
What is the all time high annual non current assets for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high annual long term assets is $472.50 M
What is Iovance Biotherapeutics annual non current assets year-on-year change?
Over the past year, IOVA annual long term assets has changed by +$287.64 M (+155.59%)
What is Iovance Biotherapeutics quarterly long term assets?
The current quarterly non current assets of IOVA is $492.54 M
What is the all time high quarterly non current assets for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high quarterly long term assets is $492.54 M
What is Iovance Biotherapeutics quarterly non current assets year-on-year change?
Over the past year, IOVA quarterly long term assets has changed by +$8.24 M (+1.70%)